N27050
yx19e05.r1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:262208 5' similar to gb:X57138_rna1 HISTONE H2B.2 (HUMAN), mRNA sequence.
327
mRNA
Homo sapiens
MD273183
JP 2020517247-A/27050: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
HW862274
JP 2015051004-A/27002: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
MB765741
JP 2018535655-A/29638: ASGR INHIBITORS.
107
PRT
synthetic construct
LX124666
JP 2017506877-A/27048: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
OG756569
JP 2021120380-A/27050: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
LF686271
JP 2016521556-A/27050: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
FU801531
JP 2009528046-A/27048: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
DL908794
JP 2014205669-A/27050: Method of constructing and screening libraries of peptide structures.
24
PRT
synthetic construct
DJ156430
JP 2007228956-A/27048: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MD759292
JP 2019507579-A/27050: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
DL617652
JP 2011092200-A/27050: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
DL036064
JP 2005512499-A/27050: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
588
DNA
synthetic construct
HW192078
JP 2013102767-A/27002: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
MC910788
JP 2018536623-A/27050: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
37
PRT
synthetic construct
PD714964
JP 2021530475-A/27046: De novo Design of Protein Switches.
55
PRT
synthetic construct
PD733286
JP 2022502046-A/37102: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
7
PRT
synthetic construct
DJ530850
JP 2010517930-A/27050: Method of constructing and screening libraries of peptide structures.
24
PRT
synthetic construct
HV883591
JP 2010507387-A/27002: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
MC168894
JP 2019500349-A/27050: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
DM763744
JP 2014079248-A/27050: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
MC555549
JP 2019525738-A/27049: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
107
PRT
synthetic construct
MC779160
JP 2018525446-A/27050: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
29
PRT
synthetic construct
OG663436
JP 2021500321-A/27050: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
PA397773
JP 2021533803-A/26856: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DM801508
JP 2014068652-A/27050: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
OG511236
JP 2018534252-A/27050: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
38
PRT
synthetic construct
DD553653
JP 2004508801-A/27050: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
DM412236
JP 2009524404-A/26222: GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION, METHODS OF DETECTION AND USES THEREOF.
201
DNA
Homo sapiens
MA194978
JP 2017060532-A/26222: GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION, METHODS OF DETECTION AND USES THEREOF.
201
DNA
Homo sapiens